|
43rd Annual Report –
2008-09
The Annual Report is a chronicle of various initiatives and multi-dimensional activities of the various OPPI Special Committees during the year
2008-09.
Price: (excluding
Service Tax)
Local – Indian Rupees: 500
International - U.S.$ 30
Download Free
42.2 Mb
Click
for more details
Order Form
|
|
OPPI
Code of
Pharmaceutical Marketing Practices - 2007
Download Free
|
|
OPPI & Ernst & Young Report 2009
- Taking Wings
Coming of age of the Indian pharmaceutical outsourcing
industry.
Download Free
Click
for more details
|
|
OPPI
Guidelines on
Cold Chain Pharmaceutical Products
Download Free
Click
for more details
|
 |
OPPI Code on Conduct of Clinical
Trials
Download Free
Click
for more details
|
|
OPPI - YES Bank Report, "Pharmaceutical Industry: Vision
2015"
Download Free
Click
for more details
|
|
OPPI – Guide to Road Safety
.
Price: (excluding
Service Tax)
Local – Indian Rupees: 20 + Courier Charges
Download Free (11.5 Mb)
Click for more details
Order
Form
|
 |
OPPI IPR Symposium Proceedings
.
Download Free (27.2 Mb)
|
 |
OPPI IPR Symposium Videos
.
Click for more details
|
 |
OPPI – Environment, Health & Safety
Guide – 2002-03
This is the Third Edition of the Guide.
Price: (excluding
Service Tax)
Local – Indian Rupees: 850
International: U.S.$ 30
Click for more details
Order
Form
|
 |
Outsourcing Opportunities in Indian
Pharmaceutical Industry
The Pharmaceutical Industry in India is
increasingly being recognised as a
reliable source of quality medicines at
affordable prices and is emerging as a
global powerhouse.
Price: (excluding
Service Tax)
Local – Indian Rupees: 1075
International: U.S.$ 40
Click for more details
Order
Form |
 |
OPPI Pharmaceutical Compendium –
(November 2004)
As we enter the Knowledge Economy, speedy and efficient exchange of reliable information will be a prime requirement for the efficient management of our intellectual capital.
Price: (excluding
Service Tax)
Local – Indian Rupees: 1,600
International: U.S.$ 80
Click for more details
Order Form
|
 |
Corporate Social Responsibility of Pharmaceutical
Companies in India: Practices, Perspectives and Way
Forward
OPPI in collaboration with S.P. Jain Institute of
Management & Research (SPJIMR) has completed the above
Research Project to study how the Pharmaceutical
Industry in India, whose primary mission is to improve
the quality of life of its customers through its
products and services, can leverage this strength for
sustainable business growth.
Price: (excluding
Service Tax)
Local: Indian Rupees 1,000
International: U.S.$ 45
Download Free (10.5 Mb)
Click for more details
Order Form
|
 |
OPPI Guidelines on Good Laboratory Practices (GLP)
This document contains Guidelines for test facilities which
are part of a manufacturing organisation that conduct
studies (tests) which are not “regulatory studies”.
Price: (excluding
Service Tax)
Local – Indian Rupees: 120
International: U.S.$ 10
Click for more details
Order Form |
 |
OPPI Anti-Counterfeiting Guidelines
Counterfeit medicines represent an unacceptable risk to patient safety whilst at the
same time jeopardizing the original manufacturer’s image, reputation and, in
extreme cases, their economic viability. It is therefore imperative that every
manufacturer of prescription and OTC medicines has in place an effective operating
procedure, to make counterfeiting difficult and, to facilitate detection and
investigation.
Price:
(excluding Service Tax)
Local: Indian Rupees 150
International: U.S.$ 10
Download Free
Click
for more details
Order Form
|